Analytical Guide

What "99% Purity" Actually Means

Purity is not one measurement. Area percentage, assay content, water and residual solvent answer different questions, and a figure without its method hides which.

[Research Use Only] This guide is for controlled laboratory research workflows only. It is not for human or veterinary use and does not provide applied-use guidance.

The number is incomplete on its own

A purity figure is the result of a specific measurement made by a specific method on a specific sample. Quoted alone it looks like a property of the material, which it is not — the same vial can honestly produce several different purity numbers depending on what was measured. The useful question is never "how pure is it" but "pure by what measure, and what did that measure exclude".

Chromatographic area percentage

This is the most commonly quoted purity figure and the most commonly over-read. It normalises one peak against the total detected response in a run, so it is bounded by what the detector responds to and by the run window. It is genuinely useful for comparing related substances that all absorb — process impurities and degradation products usually do. It is silent about anything that does not.

Measures: proportion of detected response, under one method
Blind to: substances that do not absorb at the monitored wavelength
Blind to: anything eluting outside the run window or retained on the column
Sensitive to: integration decisions, particularly where peaks are unresolved

What area percentage leaves out

For a lyophilised peptide the material in the vial is not only peptide. Synthesis and purification leave a counterion — trifluoroacetate is common where preparative chromatography used TFA — and lyophilised solids retain water. Residual solvents and inorganic residue may also be present. None of these are visible to a UV chromatogram, and together they can account for a substantial share of the mass. This is why analytical literature notes that chromatographic purity values can sit substantially above absolute purity: the method does not represent structurally unrelated substances that are transparent to the detector.

Component	Typically measured by	Visible on a UV chromatogram?
Related peptide impurities	HPLC area percentage	Yes, where they resolve
Water	Karl Fischer titration or loss on drying	No
Counterion, e.g. trifluoroacetate	Ion chromatography or a specific assay	No
Residual solvents	Gas chromatography	No
Inorganic residue	Residue on ignition	No
Peptide content	Assay against a reference standard, or amino acid analysis	Not as a percentage of mass

Each row is a separate test. A certificate reporting only the first row is not wrong; it is answering one question of several.

Assay, content and potency

Assay asks a different question: how much of the named substance is actually present, usually expressed against a reference standard and often stated on an anhydrous, counterion-free basis. Regulatory practice for peptides builds purity by mass balance — measuring the detectable impurities, including counterion, water and residual solvents, and subtracting them from 100 — rather than by reading one chromatogram. Potency, where used, is different again and refers to a measured activity rather than an amount.

Assay: how much of the named substance the sample contains
Often reported "as is" or on an anhydrous and counterion-free basis — these differ, sometimes considerably
Mass balance: purity, water and counterion assessed together rather than separately
Potency: a measured activity, not a chemical amount, and not interchangeable with either

Identity is a separate result again

None of the above establishes what the material is. A sample can be 99% of one thing by area and that thing can be something other than the substance named on the label. Identity is demonstrated by a method that examines structure, which for peptides usually means mass-based analysis and, where reported, fragmentation or sequence data. ICH Q2(R2) treats identification as demonstrating the capability to identify the analyte based on unique aspects of its molecular structure or other specific properties — a description a purity percentage does not satisfy.

How to read a purity claim

The questions that make a figure interpretable are short, and a report either answers them or does not.

By what method — and are its conditions stated?
Area percentage, or assay against a reference standard?
On what basis — as is, anhydrous, counterion-free?
Which batch, and does that batch match the vial?
When was it measured, and what has happened to the material since?
Is identity reported separately, or assumed?

Research Checklist

Confirm batch identity and records.
Document all preparation inputs.
Keep use within controlled laboratory workflows.
Do not infer applied-use suitability from guide content.

Frequently Asked Questions

Is 99% by HPLC area a meaningless number?

No — it is a real measurement and useful for what it covers, particularly related impurities that absorb. It becomes misleading only when it is read as a statement about the proportion of the vial’s mass, which is a different measurement.

Why might assay be lower than chromatographic purity?

Because assay accounts for mass that the chromatogram cannot see — water, counterion, residual solvent and inorganic residue. A material can be highly pure in terms of related substances while a meaningful share of the vial mass is not peptide.

Does a higher purity figure mean better material?

Only if the figures being compared were produced by the same measurement on the same basis. Two numbers from different methods are not comparable, and the higher one is not automatically the more rigorous.

Sources

The technical statements in this guide are drawn from the following. Where a definition is contested or a figure depends on method, the guide says so rather than picking one.

Reference Standards to Support Quality of Synthetic Peptide TherapeuticsPMC, National Library of MedicineUsed for the mass-balance approach to peptide purity — measuring related impurities, counterion, water and residual solvents and subtracting from 100 — and for assay of peptide content against a characterised standard.
Quality Control of Therapeutic Peptides by 1H NMR HiFSA SequencingPMC, National Library of MedicineUsed for the observation that chromatographic purity can exceed absolute purity because detectors do not represent structurally unrelated substances such as solvents, and for the role of counterions such as TFA in mass balance.
ICH Q2(R2): Validation of Analytical ProceduresInternational Council for Harmonisation, via the European Medicines AgencyUsed for the distinction between identification tests and assay or impurity tests, and for what an identification test is required to demonstrate.